Skip to main content
logo
Alembic Pharmaceuticals Limited (NSE:APLLTD)
India flag India · Delayed Price · Currency is INR
760.00
+2.70 (0.36%)
Jan 28, 2026, 1:40 PM IST

Alembic Pharmaceuticals Revenue

Alembic Pharmaceuticals had revenue of 19.10B INR in the quarter ending September 30, 2025, with 15.91% growth. This brings the company's revenue in the last twelve months to 70.83B, up 11.42% year-over-year. In the fiscal year ending March 31, 2025, Alembic Pharmaceuticals had annual revenue of 66.72B with 7.12% growth.

Revenue (ttm)
70.83B
Revenue Growth
+11.42%
P/S Ratio
2.10
Revenue / Employee
4.27M
Employees
16,571
Market Cap
148.86B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202566.72B4.43B7.12%
Mar 31, 202462.29B5.76B10.19%
Mar 31, 202356.53B3.47B6.54%
Mar 31, 202253.06B-873.40M-1.62%
Mar 31, 202153.93B7.87B17.10%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Piramal Pharma89.36B
Emcure Pharmaceuticals84.49B
Gland Pharma58.01B
Ajanta Pharma49.73B
Strides Pharma Science46.85B
NATCO Pharma43.90B
Wockhardt30.07B
Eris Lifesciences29.86B
Revenue Rankings

Alembic Pharmaceuticals News

More News